News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer

News

October 20, 2022
PRESS RELEASE: On October 19, 2022, a new research paper was published in Oncotarget, entitled, “Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.” continue reading »

Aging | Centenarians consistently present a younger epigenetic age than their chronological age with four epigenetic clocks based on a small number of CpG sites

Aging

October 17, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 19, entitled, “Centenarians consistently present a younger epigenetic age than their chronological age with four epigenetic clocks based on a small number of CpG sites.” continue reading »

Genes & Cancer | Splice modulating oligomers as cancer therapeutics

Genes & Cancer

October 14, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 26, 2022, entitled, “Splice modulating oligomers as cancer therapeutics.” continue reading »

Oncotarget | Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis

News

October 13, 2022
PRESS RELEASE: On October 8, 2022, a new research paper was published in Oncotarget, entitled, “Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis.” continue reading »

Oncotarget | In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained

News

October 11, 2022
PRESS RELEASE: A new Oncotarget research paper was published on October 8, 2022, entitled, “In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained.” continue reading »